|
Time
|
Topic
|
Speaker
|
Moderator
|
|
Theranosis Special Lecture
|
|
08:30-08:55
|
Where Physics Meets Biology: Quantifying the Biological Effects of Combination Treatments of Focused Ultrasound Mediated Heating and Radiotherapy
|
Gail ter Haar
(United Kingdom)
|
Hao-Li Liu
(Taiwan)
Juan Tu
(Chinese Mainland)
|
|
08:55-09:15
|
Localized Image-Guided Drug Delivery into the Brain Using Novel Transmit/Receive Ultrasound Phased Arrays
|
Kullervo Hynynen (Canada)
|
|
09:15-09:30
|
Microscale Ultrasonic Bioeffects and Their Biomedical Implications
|
Hairong Zheng (Chinese Mainland)
|
|
09:30-09:45
|
Therapeutic Applications of Microbubbles with Nanoparticle Encapsulation
|
Pai-Chi Li
(Taiwan)
|
|
09:45-10:00
|
Multifunctional Microbubbles in Ultrasound Theranostics
|
Chih-Kuang Yeh (Taiwan)
|
|
10:00-10:30
|
Coffee break
|
|
10:30-12:00
|
Opening ceremony
|
|
12:00-13:30
|
Luncheon Symposium
|
|
Keynote Speech
|
|
13:30-13:50
|
Clinical Usefulness of Contrast-Enhanced Ultrasound and Fusion Imaging in Ablation Treatment of Liver and Pancreatic Cancer
|
Fuminori Moriyasu (Japan)
|
Dirk Clevert (Germany)
Jing-Houng Wang (Taiwan)
|
|
13:50-14:10
|
Hepatic Nodules in Liver Cirrhosis: US and CEUS
|
Byung Ihn Choi (Korea)
|
|
14:10-14:30
|
Imaging of Pathologies of the Aorta by Contrast-Enhanced Ultrasound
|
Dirk Clevert (Germany)
|
|
14:30-14:50
|
The Difference between Conventional Doppler and New Advanced Doppler (Superb Micro-Vascular Imaging) and Contrast Harmonic Ultrasound and Contrast SMI on Breast Ultrasound
|
Kazutaka Nakashima (Japan)
|
|
14:50-15:10
|
Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS)
|
Christoph F. Dietrich
(Germany)
|
|
15:00-15:30
|
Coffee break
|
|
Special lecture
|
|
15:30-15:50
|
CEUS Beyond the Liver: Vascular Application. EFSUMB Guidelines and Personal Experience
|
Vito Cantisani
(Italy)
|
Christian Pállson Nolsøe
(Denmark)
Mein-Kai Gueng (Taiwan)
|
|
15:50-16:10
|
EFSUMB Non-Hepatic CEUS Guidelines – an Update
|
Paul Sidhu
(United Kingdom)
|
|
16:10-16:30
|
CEUS Guidelines: Evidence Based Medicine or off Label Use?
|
Christian Pállson Nolsøe(Denmark)
|
|
16:30-16:50
|
A Phase 3 Multicentre, Randomised, Comparative Study of the Efficacy and Safety of Sonazoid and SonoVue in Subjects with Focal Liver Lesions Undergoing Pre- and Post-Contrast Ultrasound Imaging
|
Yu-Xing Jiang (Chinese Mainland)
|
|
16:50-17:10
|
Current Status and Prospectives of CEUS in Taiwan
|
Yi-Hong Chou
(Taiwan)
|